Product Images Oxymorphone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Oxymorphone Hydrochloride NDC 63629-1925 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Struct - Structure

Struct - Structure

Table 2 - Table 2

Table 2 - Table 2

This appears to be a medical text discussing the potential risks and interactions of taking oxymorphone hydrochloride tablets with other substances such as alcohol, benzodiazepines, muscle relaxants, diuretics, and anticholinergic drugs. The text recommends careful monitoring for signs of respiratory depression and sedation, and adjusting dosages accordingly. It also suggests avoiding concomitant use of oxymorphone hydrochloride tablets with these substances if possible.*

Table 1 - Table 1

Table 1 - Table 1

Table 1 shows the adverse reactions reported in placebo-controlled trials for Oxymorphone Hydrochloride Tablets. The table lists the MedDRA Preferred Term and the percentage of patients who reported the reaction for both the Oxymorphone and Placebo groups. Some of the adverse reactions listed include Nausea, Pyrexia, Somnolence, Vomiting, Pruritus, Headache, Dizziness, Constipation, and Confusion.*

Table 3 - Table 3

Table 3 - Table 3

Table 3: Mean (+SD) Oxymorphone Hydrochloride Tablets Pharmacokinetic Parameters for different doses in single and multiple dose regimens. The table provides information on C, Auc T (ng/mL) (ng-hr/mL) after administering 5mg, 10mg, and 20mg doses. Multiple Dose regimen at varying doses was tested after five days of 6-hour dosing intervals. NA indicates not applicable.*

Label - lbl636291925

Label - lbl636291925

This is a description for a medication called NILD, containing Oxymorphone Hydrochloride tablets of 10mg each. It is advised to keep the medication out of children's reach and store it at a controlled room temperature. It must be dispensed in a light-resistant container with a child-resistant closure. The medication poses a risk of addiction and overdose, hence should be taken only under prescription. The NDC number for the medication is 63629-1925-1.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.